Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide plus laparoscopic adjustable gastric banding for diabetes control
2015-005402-11Phase 4Unknown
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Mar 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Guy's and St Thomas' NHS Foundation Trust. Primary endpoint: Change in HbA1c at 6 months. Status: unknown.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2015-005402-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005402-11.